The Journal of Experimental Medicine
for flow cytometry > invitrogen
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published online 5 March 2001.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 221K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moser, J. M.
Right arrow Articles by Lukacher, A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moser, J. M.
Right arrow Articles by Lukacher, A. E.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/2001/3/595/ $5.00
The Journal of Experimental Medicine, Volume 193, Number 5, March 5, 2001 595-606

Original Article

Antiviral Cd8+ T Cell Responses in Neonatal Mice: Susceptibility to Polyoma Virus–Induced Tumors Is Associated with Lack of Cytotoxic Function by Viral Antigen–Specific T Cells



Janice M. Mosera, John D. Altmanb,c, and Aron E. Lukachera

a Department of Pathology, Emory University School of Medicine, Atlanta, Georgia 30322
b Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia 30322
c Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia 30322
Dept. of Pathology, Woodruff Memorial Research Building, 1639 Pierce Dr., Atlanta, GA 30322.404-727-5764404-727-1896

alukach{at}emory.edu

Polyoma virus is a potent oncogenic pathogen when inoculated into newborn mice of particular H-2k strains. Using Dk tetramers containing the dominant antipolyoma CD8+ T cell epitope, middle T protein (MT)389–397, and intracellular interferon {gamma} staining, we enumerated MT389-specific CD8+ T cells in infected neonates having opposite susceptibilities to polyoma virus–induced tumors. In resistant mice, MT389-specific CD8+ T cells dramatically expanded during acute infection in neonates to a frequency rivaling that in adults; furthermore, in both neonatal and adult mice, this antipolyoma CD8+ T cell response exhibited nearly identical T cell receptor (TCR) functional avidities and TCR functional fingerprints. Susceptible mice mounted an MT389-specific CD8+ T cell response of only fourfold lower magnitude than resistant mice; but, in clear contrast to resistant mice, these CD8+ T cells lacked ex vivo MT389-specific cytotoxic activity. However, MT389-specific CD8+ T cells in resistant and susceptible mice expressed similar TCR avidities, perforin levels, and surface type O-glycan levels indicative of mature CD8+ T cell effectors. Upon in vitro restimulation with infected antigen-presenting cells, CD8+ T cells from acutely infected susceptible neonates acquired strong MT389-specific cytotoxicity. These findings indicate that polyoma-specific CD8+ T cells are armed with, but restrained from deploying, their cytotoxic effector function in mice susceptible to polyoma virus tumorigenesis.

Key Words: CD8+ T lymphocytes • intracellular IFN-{gamma} • neonatal mice • polyoma virus • tetramers

Abbreviations used in this paper: ELISPOT, enzyme-linked immunospot; MT, middle T protein.

© 2001 The Rockefeller University Press


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS